Product
Supplier
Encyclopedia
Inquiry
Home > Chemicals Market Price & Insight > Ofloxacin Market Price & Analysis > Featured News - Ofloxacin > Hongyuan Pharmaceutical achieves 878 million yuan in operating income for APIs and pharmaceutical intermediates in 2020
— Share —

Hongyuan Pharmaceutical achieves 878 million yuan in operating income for APIs and pharmaceutical intermediates in 2020

healthoo 2021-03-02
On March 1, Hubei Hongyuan Pharmaceutical Technology Co., Ltd. released its 2020 annual report.

Please sign in to view all content or subscribe.

Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.